NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
24/06/2025
Voltar para busca
Dado oficial do USPTO
CELEMICS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
27
Atualização mais recente
24/06/2025
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5, 42
Data de depósito
30/05/2023
Data de registro
24/06/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/06/2025
Última transação
24/06/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
20/02/2025
Primeiro uso no comércio
20/02/2025
Código do desenho
3
Tipo de titular
03
Localização do titular
Seoul,, KR
Examinador
LIU, PHILIP HUAI-EN
Unidade examinadora
L90
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the word "CELEMICS" with a helix to the left of the word.
Titulares e representantes
Titulares
CELEMICS, Inc.
Representantes
minchul yang STIP LAW GROUP
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Biotechnological preparationsreagents for medical purposes; pharmaceutical preparations for activating cellular function for the treatment of cancerinfectious diseaseautoimmune diseasecardiovascular diseaseallergy; chemical preparations for pharmaceutical purposesfor cancerinfectious diseaseautoimmune diseasecardiovascular diseaseallergy; chemical preparations for medical purposesfor cancerinfectious diseaseautoimmune diseasecardiovascular diseaseallergy; siccatives being drying agents for medical purposes; reagents for in-vitro laboratory use for medical purposes; cleansing solutions for medical use; reagents for medical use; drugs for medical purposespharmaceutical preparations for the treatment of cancerinfectious diseaseautoimmune diseasecardiovascular diseaseallergy; enzymes for medical purposes; enzyme preparations for medical purposes; nucleic acid sequences for medical and veterinary purposes; chemical preparations for use in DNA analysis for medical purposesfor cancerinfectious diseaseautoimmune diseasecardiovascular diseaseallergy; in vitro diagnostic preparations for medical purposes; diagnostic test reagents for medical or veterinary purposes; biological and chemical reagents for medical or veterinary purposes; reagents for use in medical genetic testing; reagents for use in veterinary genetic testing.
Classe 42
Research and development of DNA chips; structural and functional analysis of genomes; scientific laboratory services; advisory services relating to scientific research; providing information relating to scientific research; advisory services relating to biotechnology; research relating to biotechnology; biological research services; biochemical analysis; biochemistry research services; scientific research in the field of gene analysis; customized genetic scientific research; pharmaceutical research; medical research; clinical research in the field of oncologycardiovascular disease neurologyimmunologygenomics; blood testing for scientific research purposes; consultancy in analysis of biology sequence processing for medical research purposes; consultancy in analysis of genomics for medical research purposes; scientific research in the fields of biomedicine; scientific research for medical purposes in the field of cancerous diseases; scientific research for medical purposes in the area of cancerous diseases; chemical research; research for medical productsmedical research; scientific research in the nature of conducting clinical trials for others in the field of oncologycardiovascular diseaseneurologyimmunologygenomics; biotechnology research; biochemical research; providing information of scientific research.
Publicações
Histórico de despachos e eventos da marca no USPTO.
27 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
24/06/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
04/06/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
04/06/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/06/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/06/2025
EISU
TEAS STATEMENT OF USE RECEIVED
10/03/2025
IUAF
USE AMENDMENT FILED
09/03/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
24/09/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
30/07/2024
PUBO
PUBLISHED FOR OPPOSITION
30/07/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/07/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/06/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
12/06/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
12/06/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
12/06/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
12/06/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/05/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/05/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/05/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/03/2024
GNRT
NON-FINAL ACTION E-MAILED
01/03/2024
CNRT
NON-FINAL ACTION WRITTEN
01/03/2024
DOCK
ASSIGNED TO EXAMINER
22/02/2024
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
30/06/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/06/2023
NWAP
NEW APPLICATION ENTERED
02/06/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CELEMICS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.